Literature DB >> 19144472

The Pringle manoeuvre should be avoided in hepatectomy for cancer patients due to its side effects on tumor recurrence and worse prognosis.

Feng Xiaobin1, Liu Zipei, Zheng Shuguo, Dong Jiahong, Li Xiaowu.   

Abstract

Curative hepatectomy is still the best therapeutic strategy for liver cancer treatment up to now. The Pringle manoeuvre has been commonly used to avoid massive blood loss during operation since its advent, which greatly accelerates the advance of liver surgery and oncological surgery. In the past century, more attentions have been paid to different effects of ischemia-reperfusion injury elicited by Pringle manoeuvre. Theses include its impacts on complex metabolic, immunological, and microvascular changes, which altogether might contribute to hepatocellular damage and dysfunction, and contribute to haemodynamic instability. Despite these adverse impacts, the short-term outcome of affected patients under hepatectomy was greatly improved with the advances of surgical techniques and perioperative management in recent years. While the long-term prognosis remains unsatisfactory due to a high incidence of intra/extrahepatic recurrence. The reason for it was not totally elucidated. Furthermore, the effect of the Pringle manoeuvre on the prognosis of oncologic patients and behavior of the tumor cell was not deliberately mentioned. This point was put forward to the front-desk by the specific phenomenon from recent animal studies. It is showed that ischemia-reperfusion injury of the liver remnant may be a significant factor to promote the tumor recurrence and metastasis. If it is a truth in human, there must be a big challenge to the Pringle manoeuvre. So we hypothesized that the long-term prognosis of cancer patients could be worsened by the ischemia-reperfusion injury elicited by Pringle manoeuvre during the hepatectomy and it should be revised, or even, avoided in future hepatectomy for oncologic patients. The less surgical stress including ischemia-reperfusion injury in the hepatic resection without Pringle manoeuvre might contribute to a better prognosis. To get a deeper understanding, prospective randomized clinical trials need to be done. It is surely supposed to provide more important information about the long-term effects of the Pringle manoeuvre, and to our hypothesis.

Entities:  

Mesh:

Year:  2009        PMID: 19144472     DOI: 10.1016/j.mehy.2008.11.029

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

Review 1.  [Liver transection: modern procedure: Technique, results and costs].

Authors:  H Bruns; M W Büchler; P Schemmer
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

Review 2.  Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion.

Authors:  Mahmoud Abu-Amara; Kurinchi Gurusamy; Satoshi Hori; George Glantzounis; Barry Fuller; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

3.  Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial.

Authors:  Yinzhe Xu; Jiye Chen; Hongguang Wang; Hui Zheng; Dan Feng; Aiqun Zhang; Jianjun Leng; Weidong Duan; Zhanyu Yang; Mingyi Chen; Xianjie Shi; Shouwang Cai; Wenbin Ji; Kai Jiang; Wenzhi Zhang; Yongliang Chen; Wanqing Gu; Jiahong Dong; Shichun Lu
Journal:  Trials       Date:  2016-10-11       Impact factor: 2.279

4.  Selective Hemihepatic Vascular Occlusion Versus Pringle Maneuver in Hepatectomy for Primary Liver Cancer.

Authors:  Minghao Li; Tao Zhang; Liyun Wang; Baoding Li; Yang Ding; Chunyan Zhang; Saiwu He; Zhiqi Yang
Journal:  Med Sci Monit       Date:  2017-05-09

5.  Effect of the pringle maneuver on tumor recurrence of hepatocellular carcinoma after curative resection (EPTRH): a randomized, prospective, controlled multicenter trial.

Authors:  Feng Xiaobin; Zheng Shuguo; Zhou Jian; Qiu Yudong; Liang Lijian; Ma Kuansheng; Li Xiaowu; Xia Feng; Yi Dong; Wang Shuguang; Bie Ping; Dong Jiahong
Journal:  BMC Cancer       Date:  2012-08-03       Impact factor: 4.430

6.  Comparing outcomes of two vascular inflow occlusion techniques and treatment without vascular occlusion during major hepatectomy in patients with Hepatitis B-related hepatocellular carcinoma.

Authors:  Zhiping Huang; Peng Zhang; Haiqing Wang; Lunan Yan; Wentao Wang
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.